High plasma brain natriuretic polypeptide level as a marker of risk for thromboembolism in patients with nonvalvular atrial fibrillation

Stroke

Volumn 33, Issue 4, 2002, Pages 1005-1010

  Shimizu, Hiromi ^a   Murakami, Yo ^a   Inoue, Shin Ichi ^a   Ohta, Yoko ^a   Nakamura, Ko ^a   Katoh, Harumi ^a   Sakne, Takeshi ^a   Takahashi, Nobuyuki ^a   Ohata, Shuzo ^a   Sugamori, Takashi ^a   Ishibashi, Yutaka ^a   Shimada, Toshio ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

Atrial fibrillation; Natriuretic peptide, brain; Thromboembolism

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; POLYPEPTIDE;

ADULT; AGED; ARTICLE; BLOOD FLOW VELOCITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; FEMALE; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FUNCTION; HIGH RISK POPULATION; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; THROMBOEMBOLISM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; ATRIAL APPENDAGE; ATRIAL FIBRILLATION; ATRIAL FUNCTION, LEFT; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; BLOOD FLOW VELOCITY; CHRONIC DISEASE; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; THROMBOEMBOLISM;

EID: 0036213181     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/hs0402.105657     Document Type: Article

References (37)

1. Atrial fibrillation as an independent risk factor for stroke: The Framingham study
2. Prevalence of cardiovascular disease and diabetes mellitus in residents of Rochester, Minnesota
3. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study)
4. Thromboembolic complications in atrial fibrillation
5. Lone atrial fibrillation and stroke
6. Diagnosis of left atrial appendage thrombi by transesophageal echocardiography: Clinical implications and follow-up
7. Left atrial spontaneous echo contrast: A clinical and echocardiographic analysis
8. Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo
9. Multiplane transesophageal echocardiographic assessment of left atrial appendage anatomy and function
10. Usefulness of multiplane transesophageal echocardiography in differentiating left atrial appendage thrombus from pectinate muscles
11. Anatomy of the normal left atrial appendage: A quantitative study of age-related changes in 500 autopsy hearts: Implications for echocardiographic examination
12. Echocardiographic assessment of the left atrial appendage
13. Assessment of left atrial appendage function by transesophageal echocardiography: Implications for the development of thrombus
14. Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation. I: Reduced flow velocity in the left atrial appendage (the Stroke Prevention in Atrial Fibrillation [SPAF-III] study)
15. Influence of left atrial function on Doppler transmitral and pulmonary venous flow patterns in dilated and hypertrophic cardiomyopathy: Evaluation of left atrial appendage function by transesophageal echocardiography
16. Assessment of left atrial appendage function by biplane transesophageal echocardiography in patients with nonrheumatic atrial fibrillation: Identification of a subgroup of patients at increased embolic risk
17. Relationship between flow dynamics in the left atrium and hemostatic abnormalities in patients with nonvalvular atrial fibrillation
18. Platelet activation in embolic and preembolic status of patients with nonrheumatic atrial fibrillation
19. Natriuretic peptide system in human heart failure
20. Contribution of endogenous nitric oxide to basal vasomotor tone of peripheral vessels and plasma B-type natriuretic peptide levels in patients with congestive heart failure
21. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure
22. Marked expression of plasma brain natriuretic peptide is a special feature of hypertrophic obstructive cardiomyopathy
23. Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation
24. Drop in plasma brain natriuretic peptide levels after successful direct current cardioversion in chronic atrial fibrillation
25. Brain natriuretic peptide as a novel cardiac hormone in humans: Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide
26. Biochemical detection of left-ventricular systolic dysfunction
27. Safety of transesophageal echocardiography: A multicenter survey of 10 419 examinations
28. Correlation between left atrial size, prothrombotic state and markers of endothelial dysfunction in patients with lone chronic nonrheumatic atrial fibrillation
29. Haemostatic and haemodynamic abnormalities associated with left atrial thrombosis in non-rheumatic atrial fibrillation
30. Hypercoagulability and chronic atrial fibrillation: The role of markers of thrombin generation
31. Relationship between plasma atrial and brain natriuretic peptide concentration and hemodynamic parameters during percutaneous transvenous mitral valvulotomy in patients with mitral stenosis
32. Plasma atrial and brain natriuretic peptides in mitral stenosis treated by valvulotomy
33. Relation between left atrial dimension and duration of atrial fibrillation
34. Atrial fibrillation and left atrial enlargement: Cause or effect?
35. Left atrial diameter in nonvalvular atrial fibrillation: An echocardiographic study: Stroke Prevention in Atrial Fibrillation Investigators
36. The histopathological substratum for atrial fibrillation in man
37. Histological substrate of atrial biopsies in patients with lone atrial fibrillation